Literature DB >> 8652546

Erythromycin biosynthesis: kinetic studies on a fully active modular polyketide synthase using natural and unnatural substrates.

R Pieper1, S Ebert-Khosla, D Cane, C Khosla.   

Abstract

6-Deoxyerythronolide B synthase (DEBS) is a modular polyketide synthase (PKS) that catalyzes the biosynthesis of the parent macrolide of erythromycin. On the basis of a recently developed cell-free assay (Pieper et al., 1995a) we report the results of steady-state kinetic studies on a modular PKS. A truncated form of DEBS (DEBS 1+TE), in which DEBS 1 is fused to the thioesterase domain from the C-terminal end of DEBS 3, was used for most of these studies. The overall k(cat) for (2S,3S,4S,5R)-2,4-dimethyl-3,5-dihydroxy-n-heptanoic acid delta-lactone (C9-lactone) synthesis is 3.4 min(-1), indicating that the enzyme is at least as active in vitro as in vivo. The apparent K(m) for (2S)-methylmalonyl-CoA consumption by DEBS 1+TE is 24 microM. The catalytic activity of DEBS 1+TE is strongly dependent on the phosphate concentration in the reaction buffer in the range 0-250 mM, suggesting that hydrophobic interactions may be crucial to the assembly of DEBS monomers into a functional complex. Although DEBS 1+TE can convert acetyl-, propionyl-, or butyryl-CoA into the corresponding C8-, C9-, and C10-lactones (Pieper et al., 1995b), it has a 32-fold preference for a propionate primer over an acetate primer and a 7.5-fold preference for a propionate primer over a butyrate primer. In the absence of any added primer unit, synthesis can be primed via decarboxylation of methylmalonyl-CoA; under these conditions the overall k(cat) for polyketide synthesis remains unchanged. Decarboxylation of methylmalonyl-CoA is negligible in the presence of saturating concentrations of propionyl-CoA but competes with the priming of the enzyme by acetyl-CoA or butyryl-CoA. The k(cat) for 6-deoxyerythronolide B synthesis by the complete DEBS is 0.5 min(-1). Under these assay conditions, the C9-lactone is also produced as an abortive chain elongation product with a k(cat) of 0.23 min(-1), presumably due to inefficient assembly of the multimeric protein complex involving DEBS 1, 2, and 3. Together, these results provide the first comprehensive kinetic insights into a fully active modular PKS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8652546     DOI: 10.1021/bi952860b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  Leveraging microbial biosynthetic pathways for the generation of 'drop-in' biofuels.

Authors:  Amin Zargar; Constance B Bailey; Robert W Haushalter; Christopher B Eiben; Leonard Katz; Jay D Keasling
Journal:  Curr Opin Biotechnol       Date:  2017-04-17       Impact factor: 9.740

2.  Connection of propionyl-CoA metabolism to polyketide biosynthesis in Aspergillus nidulans.

Authors:  Yong-Qiang Zhang; Matthias Brock; Nancy P Keller
Journal:  Genetics       Date:  2004-10       Impact factor: 4.562

3.  Roles of Conserved Active Site Residues in the Ketosynthase Domain of an Assembly Line Polyketide Synthase.

Authors:  Thomas Robbins; Joshuah Kapilivsky; David E Cane; Chaitan Khosla
Journal:  Biochemistry       Date:  2016-08-03       Impact factor: 3.162

4.  Investigating the reactivities of a polyketide synthase module through fluorescent click chemistry.

Authors:  Amanda Jane Hughes; Matthew R Tibby; Drew T Wagner; Johnathan N Brantley; Adrian T Keatinge-Clay
Journal:  Chem Commun (Camb)       Date:  2013-11-06       Impact factor: 6.222

Review 5.  The type I fatty acid and polyketide synthases: a tale of two megasynthases.

Authors:  Stuart Smith; Shiou-Chuan Tsai
Journal:  Nat Prod Rep       Date:  2007-07-02       Impact factor: 13.423

6.  Biochemical characterization of the minimal domains of an iterative eukaryotic polyketide synthase.

Authors:  Martin Sabatini; Santiago Comba; Silvia Altabe; Alejandro I Recio-Balsells; Guillermo R Labadie; Eriko Takano; Hugo Gramajo; Ana Arabolaza
Journal:  FEBS J       Date:  2018-10-25       Impact factor: 5.542

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.